Τόμος 28 (2010) – Τεύχος 2 – Άρθρο 6 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 28 (2010) – Issue 2 – Article 6 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Διατατική Μυοκαρδιοπάθεια – Μαγνητική Τομογραφία Καρδίας

Dilated cardiomyopathy – Cardiac MRI

Ψυχίδης,Π., Δημητριάδης,Α.Σ. : Διατατική Μυοκαρδιοπάθεια – Μαγνητική Τομογραφία Καρδίας, Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 28: 139-142 (2010)

Psychidis,P., Dimitriadis,A.S. : Dilated cardiomyopathy – Cardiac MRI, Epitheorese Klin. Farmakol. Farmakokinet. 28: 139-142 (2010)

Ελληνικά – Greek

‘Αρθρο

Article

–

Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and systolic dysfunction. The primary diagnostic issue centers on differentiating dilated cardiomyopathy from coronary artery disease. Cardiac MRI is the gold standard non invasive method for the assessment of global and regional left ventricular function, for measurement of blood flow and for the detection of endocardial thrombi. Furthermore CMRI has well established imaging capabilities for myocardial caracterization. With the delayed enhancement technique myocadial scarring or interstitial fibrosis can be depicted. The pattern and the distribution of late enhancement within the myocardium allow ischemic and non ischemic myocardial damage to be distiguished. In a single examination CMRI can provide an accurate functional analysis, support the diagnosis of dilated cardiomyopathy and rule out complications associated with the disease.